Skip to main content

RETRACTION article

Front. Cell. Neurosci., 08 February 2022
Sec. Cellular Neuropathology
Volume 16 - 2022 | https://doi.org/10.3389/fncel.2022.858255

Retraction: Long Non-coding RNA LINC00320 Inhibits Tumorigenicity of Glioma Cells and Angiogenesis Through Downregulation of NFKB1-Mediated AQP9

This article is a retraction of:

  1. RETRACTED: Long Non-coding RNA LINC00320 Inhibits Tumorigenicity of Glioma Cells and Angiogenesis Through Downregulation of NFKB1-Mediated AQP9

    1. Read original article
\nFrontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Long Non-coding RNA LINC00320 Inhibits Tumorigenicity of Glioma Cells and Angiogenesis Through Downregulation of NFKB1-Mediated AQP9

by Chang, L., Bian, Z., Xiong, X., Liu, J., Wang, D., Zhou, F., Zhang, J., and Zhang, Y. (2020). Front. Cell. Neurosci. 14:542552. doi: 10.3389/fncel.2020.542552

The journal and Chief Editors retract the 22 December 2020 article cited above.

Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies. Given the concerns, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Editors of Frontiers in Cellular Neuroscience and the Chief Executive Editor of Frontiers. The authors agreed with this retraction.

Citation: Frontiers Editorial Office (2022) Retraction: Long Non-coding RNA LINC00320 Inhibits Tumorigenicity of Glioma Cells and Angiogenesis Through Downregulation of NFKB1-Mediated AQP9. Front. Cell. Neurosci. 16:858255. doi: 10.3389/fncel.2022.858255

Received: 19 January 2022; Accepted: 19 January 2022;
Published: 08 February 2022.

Approved by: Dirk M. Hermann, University of Duisburg-Essen, Germany

Copyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZSYjeDAwMDQwO2Zyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.